Virus News and Research

Latest Virus News and Research

Scientists identify compounds that block replication of COVID-19 virus

As the death toll from the COVID-19 pandemic mounts, scientists worldwide continue their push to develop effective treatments and a vaccine for the highly contagious respiratory virus.

7 Jul 2020

Faulty immune response to SARS-CoV-2 one of the main causes of death

A new study published on the preprint server medRxiv in July 2020 describes the organ and tissue-specific spread of the virus causing the current COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

7 Jul 2020

SARS-CoV-2 detected in Santiago, Chile wastewater with very little loss of viral RNA

A preliminary report from Chile describes the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in sewage as a sensitive method to assess the circulation of viruses within a community.

7 Jul 2020

Dutch trial of convalescent plasma in COVID-19 discontinued

Now, a recent trial published on the preprint server medRxiv* in July 2020 reports that a majority of hospitalized COVID-19 patients have a high titer of neutralizing antibodies, at the time of admission, within 10 days of symptomatic disease.

7 Jul 2020

Viral and bacterial co-infections are pervasive in severe COVID-19 patients

A large group of researchers from China recently characterized microbial co-infections in the respiratory tract of hospitalized coronavirus disease (COVID-19) patients and demonstrated a high prevalence of both viral and bacterial co-infections – particularly in individuals presenting with severe disease.

6 Jul 2020

Airborne spread of SARS-CoV-2 possible and should not be ignored

Researchers at the National Institute for Public Health and the Environment in the Netherlands say that airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is possible and should not be discounted.

6 Jul 2020

Doping agent Epo could be effective against Covid-19

Erythropoietin (Epo) is actually a medication for anaemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against Covid-19.

6 Jul 2020

COVID-19 risk halved when airplane middle seats empty, expert statistician says

As the coronavirus cases skyrocket, many countries have started to ease lockdown measures to save the ailing economy. Restaurants, malls, recreational centers, and transportation are slowly returning to normal operations. However, one of the most heavily impacted sectors amid the pandemic is the aviation industry.

6 Jul 2020

Work begins on UK-wide system for detecting coronavirus in wastewater

Scientists will develop a standardized UK-wide system for detecting coronavirus in wastewater, in order to provide an early warning of future outbreaks and reduce reliance on costly testing of large populations.

6 Jul 2020

Mongolia warns of suspected bubonic plague

Mongolia has issued a warning to residents in the western Khovd region after two people are suspected of having the bubonic plague. The National Center for Zoonotic Diseases (NCZD) states that the disease is linked to the consumption of marmots, a relatively large ground squirrel.

6 Jul 2020

COVID-19 complications may be associated with von Willebrand factor in the blood

Anna Aksenova, a senior research associate at the Laboratory of Amyloid Biology at St Petersburg University, has advanced a hypothesis that the severe course of COVID-19 may be associated with von Willebrand factor.

6 Jul 2020

Obesity and BME status may place individuals at high-risk of contracting COVID-19

Obese people among black and minority ethnic communities (BME) are at around two times higher the risk of contracting COVID-19 than white Europeans, a study conducted by a team of Leicester researchers has found.

6 Jul 2020

Researchers develop new tool to visualize worldwide trends in coronavirus infection

Austrian researchers have developed a simple tool to show the trends in coronavirus infections over time around the world.

6 Jul 2020

Social media image about mask efficacy right in sentiment, but percentages are ‘bonkers’

A popular social media post that's been circulating on Instagram and Facebook since April depicts the degree to which mask-wearing interferes with the transmission of the novel coronavirus.

6 Jul 2020

Coronavirus crisis disrupts treatment for another epidemic: Addiction

Shawn Hayes was thankful to be holed up at a city-run hotel for people with COVID-19.

6 Jul 2020

Asthma does not appear to increase the risk of COVID-19, shows study

Asthma does not appear to increase the risk for a person contracting COVID-19 or influence its severity, according to a team of Rutgers researchers.

6 Jul 2020

Cell 'membrane on a chip' could help test potential drug candidates for COVID-19

Researchers have developed a human cell 'membrane on a chip' that allows continuous monitoring of how drugs and infectious agents interact with our cells, and may soon be used to test potential drug candidates for COVID-19.

6 Jul 2020

WHO urged to recognize airborne transmission of COVID-19

Now, a team of international scientists, including 239 health experts from 32 countries, has written an open letter to the WHO urging the organization to revise its recommendations for the spread of SARS-CoV-2, due to mounting evidence that the disease is airborne for more extended periods than the WHO advisory.

6 Jul 2020

Oxford COVID-19 vaccine trials move to stage 3 human trials

The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.

5 Jul 2020

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

A new study involving over 92,000 patients with COVID-19 in Brazil shows that the odds of severe disease, ventilatory support requirement, and death are reduced with a recent trivalent flu vaccine. This seems to indicate that these vaccines should be used as widely as possible to reduce the risk of severe COVID-19, especially among high-risk groups. The study is published on the preprint server medRxiv* in June 2020.

5 Jul 2020